Catheter News and Research

RSS

In medicine, a catheter is a tube that can be inserted into a body cavity, duct, or vessel. Catheters . In most uses, a catheter is a thin, flexible tube ("soft" catheter), though in some uses, it is a larger, solid ("hard") catheter. A catheter left inside the body, either temporarily or permanently, may be referred to as an indwelling catheter. A permanently inserted catheter may be referred to as a permcath.

Registration open for Society of Interventional Radiology's Annual Scientific Meeting

Online meeting registration is open for the Society of Interventional Radiology's Annual Scientific Meeting April 13 at the Ernest N. Morial Convention Center in New Orleans.

1 Mar 2013

Abell Foundation to award $50,000 to 3 Johns Hopkins researchers for medical inventions

Johns Hopkins' John Wong, Ph.D., has won a BioMaryland LIFE Award, and Ronald Berger, M.D., Ph.D., and Hien Nguyen, M.D., were awarded funds from the Abell Foundation, the researchers learned last week. Each of the winners will receive $50,000 to help develop their discoveries for clinical use.

27 Feb 2013

Surefire Medical’s latest line of infusion system and specialty catheters receive CE Mark approval

Surefire Medical, Inc., the developer of a new class of infusion systems designed to maximize targeted delivery of embolization agents without reflux, today announced CE Mark approval for its Surefire Infusion System ST/LT and Surefire Specialty Catheters.

26 Feb 2013

Catheters may increase risk of death, infections and cardiovascular events in dialysis patients

Dialysis patients using catheters to access the blood have the highest risks for death, infections, and cardiovascular events compared with patients using other types of vascular access, according to an analysis appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

22 Feb 2013

International nonproprietary name “auriclosene” approved by WHO for NovaBay’s NVC-422

NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biotechnology company focused on addressing the large unmet therapeutic needs of the global anti-infective market with first-in-class compounds such as its proprietary Aganocides®, today announced that the World Health Organization (WHO) has approved the international nonproprietary name (INN) “auriclosene” (pronounced awr-rih-CLO-zeen) for the Company’s lead Aganocide® compound NVC-422.

21 Feb 2013

Clot evacuation reduces perihematomal edema in hemorrhagic stroke

Minimally invasive surgery combined with recombinant tissue-type plasminogen activator significantly reduces perihematomal edema in patients with intracerebral hemorrhage.

18 Feb 2013

Frequent dialysis: it’s complicated

Patients who undergo hemodialysis on a frequent basis are at an increased risk for vascular access complications, requiring more vascular repair procedures to enable continued access to the blood, report Canadian researchers.

15 Feb 2013

ReCor Medical initiates PARADISE system post-market study in high blood pressure

ReCor Medical announced today that it has commenced a 50-patient, post-market study across multiple sites in Europe with its CE-marked next-generation PARADISE system, a minimally invasive 6Fr Over-The-Wire (OTW) ultrasound device for treating resistant high blood pressure.

15 Feb 2013

FDA grants IDE approval to STS and ACC to study alternative access approaches for TAVR

The Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC) have received a unique investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to study "alternative access" approaches for transcatheter aortic valve replacement (TAVR) using the STS/ACC TVT Registry.

14 Feb 2013

Bedside baths and bloodstream infections in children: an interview with Aaron Milstone

Bedside baths in the hospital are nothing new. They are typically done for patient comfort and to maintain basic personal hygiene.

13 Feb 2013

Strokes that occur during or shortly after surgery can be devastating

Strokes that occur during or shortly after surgery can be devastating, resulting in longer hospital stays and increased risks of death or long-term disability.

12 Feb 2013

U.S. hospitals continue to make progress in reducing health care-associated infections

Hospitals in the U.S. continue to make progress in the fight against central line-associated bloodstream infections and some surgical site infections, according to a report issued today by the Centers for Disease Control and Prevention (CDC). Catheter-associated urinary tract infections remained unchanged between 2010 and 2011.

12 Feb 2013

Parenteral nutrition safety: an interview with Dr. Phil Ayers, A.S.P.E.N PN Safety Task Force Chair and Dr. Peggi Guenter, Director of the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)

Parenteral nutrition is intravenous nutrition for patients who are unable to eat or be tube fed. It is used with more than 300,000 patients per year - a quarter of whom are children and newborns.

11 Feb 2013

Intra-arterial therapy no more effective than IV t-PA in treating acute ischemic stroke

A stroke survivor's chances of living independently after 90 days are not improved by the use of devices inserted into the artery to dissolve or remove a stroke-causing clot shortly after the onset of symptoms, according to a randomized controlled trial involving 656 patients.

11 Feb 2013

Cedars-Sinai to include more patients in hypothermia plus clot-busting drug trial for stroke

An international multicenter clinical trial led by a Cedars-Sinai neurologist on the combination of brain cooling and "clot-busting" drug therapy after stroke has received Food and Drug Administration approval to expand from 50 patients to 400.

7 Feb 2013

Chlorhexidine bathing protects vulnerable hospital patients

Bathing hospital patients with chlorhexidine-impregnated washcloths reduces the risk for them acquiring multidrug-resistant organisms and developing bloodsteam infections, show study findings.

7 Feb 2013

ZOLL's Intravascular Temperature Management solution receives Shonin approval in Japan

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, has received Shonin approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) to enter the Japanese market with its Intravascular Temperature Management (IVTM) technology—the first intravascular temperature management system to receive Shonin approval in Japan.

6 Feb 2013

St. Jude Medical initiates Portico Transfemoral European Trial in severe aortic stenosis

St. Jude Medical, Inc., a global medical device company, today announced the first patient implant of its 25 mm Portico Transcatheter Aortic Heart Valve using the Transfemoral Delivery System in its ongoing European trial.

5 Feb 2013

Consensus move promotes radial access for coronary intervention

A European consensus document aims to encourage interventionalists to choose radial artery over femoral artery access where possible when performing percutaneous coronary intervention.

4 Feb 2013

Certified IPs more likely to perceive evidence behind infection prevention practices

There is general agreement among hospital infection preventionists (IPs) with respect to which practices have weak or strong evidence supporting their use to prevent healthcare-associated infection, according to a new study published in the February issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).